Gorlin SyndromediagnosisBCCdermatologyScience Articlesbasal cell carcinomapathologyWeakly supervised detection and classification of basal cell carcinoma using graph-transformer on whole slide images
Gorlin SyndromeBCCbasal cell carcinomatreatmentresearch summaryProspective Study on Deep Shave Removal of BCC
Gorlin Syndromeprognosisnonmelanoma skin cancersBCCdermatologyScience Articlespresentationbasal cell carcinomaThe Rise of Basal Cell and Squamous Cell Carcinomas: What’s the Difference?
Gorlin SyndromepathophysiologypreventiondiagnosisBCCdetectiondermatologyScience Articlesrisk factorspresentationbasal cell carcinomatreatmentBasal Cell Carcinoma
Gorlin Syndromeskin cancerdetectiondermatologyScience Articlesrisk factorspresentationWhere the Sun Doesn’t Shine: The Hidden Areas Where Skin Cancer Can Pop Up
Gorlin SyndromeUncategorizedVP-315BCCbasal cell carcinomaVerrica Pharmaceuticals Announces Dosing of the First Patient in Part 2 of Phase 2 Study Evaluating VP-315 for the Treatment of Basal Cell Carcinoma
Gorlin Syndromeinterdisciplinary careBCCbasal cell carcinomamanagementtreatmentExpert Perspectives on the Role of Interdisciplinary Care in BCC
ResourcesdiagnosisBCCResearchdermatologyScience Articlesrisk factorspresentationbasal cell carcinomatreatmentBasal Cell Carcinoma: a Review
odontogenic keratocystcase reportUncategorizedtreatmentModel-assisted marsupialization of a large odontogenic keratocyst in the maxillofacial region using a multicolored 3D-printed model: A novel approach in surgical planning and teaching
UncategorizedpharmaceuticalsResourcesBCCResearchbasal cell carcinomatreatmentforecastBasal Cell Carcinoma Therapeutics Industry Consumption Analysis, Business Overview and Upcoming Trends 2030
%20(2)-1.png?width=200&height=85&name=GSA%20Logo%20High%20Res%20No%20Background%20(1)%20(2)-1.png)
